Status:
COMPLETED
Study on Prevention of SARS-CoV-2 Transmission During a Large Indoor Gathering Event
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
PRODISS
WEEZEVENT
Conditions:
Covid19
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
The objective is to demonstrate if there is no increase in the risk of Sars-Cov-2 salivary carriage 7 days after a concert in the group participating in the event compared to a non participating group...
Detailed Description
Before inclusion, the participants will be able to pre-register to the event via a website. They will get an appointment for an inclusion visit at the Accor Arena (Paris Bercy, France). During 3 days...
Eligibility Criteria
Inclusion
- aged between 18 and 45 years old
- lack of symptoms or no contact with people with Covid-19 in the last two weeks
- negative antigenic test to Covid-19 in the 3 days before the experiment
- people who declared to have no risk factor to severe form of Covid-19
- people who declared not to live in the same place as someone with these risk factors
- people residing in Ile-de-France area
Exclusion
- positive test to Sars-Cov-2 within 3 days before the concert
- people with clinical signs suggesting infectious respiratory disease
- people with severe Covid-19 risk factor
- people living with someone having severe covid-19 risk factor
- not affiliated to social security
- people who cannot remain standing for the time of the experimentation (about 5 hours)
- person under tutorship or curatorship
- pregnant women or not having effective contraception method
- breastfeeding women
Key Trial Info
Start Date :
May 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 13 2021
Estimated Enrollment :
6678 Patients enrolled
Trial Details
Trial ID
NCT04872075
Start Date
May 26 2021
End Date
June 13 2021
Last Update
November 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AccorHotels Arena
Paris, France, 75012